Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marian J Mourits

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|June 1, 2017
European/U.S. Comparison and Contrasts in Ovarian Cancer Screening and Prevention in a High-Risk PopulationMarian J Mourits, G H de Bock
Annals of Translational Medicine|February 5, 2020
Before it catches the eye…Marian J Mourits, Geertruida H de Bock
BMJ (Clinical Research Ed.)|October 8, 2009
Symptoms are not early signs of ovarian cancerMarian J Mourits, Geertruida H de Bock
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 4, 2015
Pathologic findings at risk-reducing surgeryMarian J Mourits, Geertruida H de Bock, Harry Hollema
Maturitas|September 21, 2017
Health and wellbeing after cancerSerge Rozenberg, Angela Maas, Marian J Mourits, et al.
Maturitas|June 5, 2014
Genetic testing and familial implications in breast-ovarian cancer familiesJan C Oosterwijk, Jakob de Vries, Marian J Mourits, et al.
Gynecologic Oncology|December 4, 2015
Inverse birth cohort effects in ovarian cancer: Increasing risk in BRCA1/2 mutation carriers and decreasing risk in the general populationJanet R Vos, Marian J Mourits, Natalia Teixeira, et al.
BMC Women'S Health|March 19, 2020
Feasibility of endometrial sampling by vaginal tampons in women with Lynch syndromeJorien M Woolderink, Geertruida H De Bock, Bettien M van Hemel, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 8, 2017
The BRCA1/2 Parent-of-Origin Effect on Breast Cancer Risk-ResponseJanet R Vos, Jan C Oosterwijk, Matti A Rookus, et al.
Maturitas|November 26, 2013
Risk-reducing mastectomy in BRCA1/2 mutation carriers: factors influencing uptake and timingCatheleine M van Driel, Yassir Eltahir, Jakob de Vries, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|June 1, 2017
European/U.S. Comparison and Contrasts in Ovarian Cancer Screening and Prevention in a High-Risk PopulationMarian J Mourits, G H de Bock
Annals of Translational Medicine|February 5, 2020
Before it catches the eye…Marian J Mourits, Geertruida H de Bock
BMJ (Clinical Research Ed.)|October 8, 2009
Symptoms are not early signs of ovarian cancerMarian J Mourits, Geertruida H de Bock
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 4, 2015
Pathologic findings at risk-reducing surgeryMarian J Mourits, Geertruida H de Bock, Harry Hollema
Maturitas|September 21, 2017
Health and wellbeing after cancerSerge Rozenberg, Angela Maas, Marian J Mourits, et al.
Maturitas|June 5, 2014
Genetic testing and familial implications in breast-ovarian cancer familiesJan C Oosterwijk, Jakob de Vries, Marian J Mourits, et al.
Gynecologic Oncology|December 4, 2015
Inverse birth cohort effects in ovarian cancer: Increasing risk in BRCA1/2 mutation carriers and decreasing risk in the general populationJanet R Vos, Marian J Mourits, Natalia Teixeira, et al.
BMC Women'S Health|March 19, 2020
Feasibility of endometrial sampling by vaginal tampons in women with Lynch syndromeJorien M Woolderink, Geertruida H De Bock, Bettien M van Hemel, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 8, 2017
The BRCA1/2 Parent-of-Origin Effect on Breast Cancer Risk-ResponseJanet R Vos, Jan C Oosterwijk, Matti A Rookus, et al.
Maturitas|November 26, 2013
Risk-reducing mastectomy in BRCA1/2 mutation carriers: factors influencing uptake and timingCatheleine M van Driel, Yassir Eltahir, Jakob de Vries, et al.
Pageof 2